Ravi K. Jalluri - Division of Cancer Treatment and Diagnosis, National Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 48 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 4486: Characterization of a novel mutant selective, EGFR sparing, ErbB2 inhibitor with activity across activating mutations in systemic and CNS tumors

Jennifer Fulton, Tanna Bettendorf, Abiezer Blandon,Karyn Bouhana, Richard K. Brizendine,LouAnn Cable,Mark J. Chicarelli, Michelle Crow,Brad Fell,John Fischer,Anna Guarnieri, Madison Hillman,

Cancer Researchno. 6_Supplement (2024): 4486-4486

Cited0Views0Bibtex

Abstract PO3-26-01: Preclinical in vitro and in vivo characterization of a novel, wild-type-sparing, PI3Kα H1047R mutant-selective inhibitor

Aaron C. Smith, Ben Arwood-Levine, Alexandra Born, Richard Brizendine, Payal Chatterjee,Mark J. Chicarelli, Michael L. Conner,Brad Fell,Jennifer Fulton,Anna Guarnieri,Ravi Jalluri, Hailey Knox,

Cancer Researchno. 9_Supplement (2024): PO3-26

Cited0Views0Bibtex

Abstract PO3-26-02: Identification of a novel, brain penetrant, EGFR sparing, ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Mark J. Chicarelli, Ben Arwood-Levine, Tanna Bettendorf,Karyn Bouhana, Richard Brizendine,LouAnn Cable, Michelle Crow,Brad Fell,John Fischer,Jennifer Fulton,Anna Guarnieri, Madison Hillman,

Cancer Researchno. 9_Supplement (2024): PO3-26

Cited0Views0Bibtex

Abstract 1439: In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

J. E. Fischer,Karyn Bouhana,Mark Chicarelli,Brad Fell,Jennifer Fulton, Anna L. Guarnieri, Leyla Haygood,Ravi Jalluri,Amber Johnson, Brent Mclean, Max Mejia,Rob Rieger,

Cancer Researchno. 7_Supplement (2023): 1439-1439

Cited0Views0Bibtex

In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

John Fischer,Karyn Bouhana,Mark Chicarelli,Brad Fell,Jennifer Fulton,Anna Guarnieri, Leyla Haygood,Ravi Jalluri,Amber Johnson, Brent Mclean, Max Mejia,Rob Rieger,

CANCER RESEARCHno. 7 (2023)

Cited0Views0Bibtex

Abstract 1440: Identification of a novel EGFR sparing brain penetrant ErbB2 inhibitor with activity against oncogenic ErbB2 mutations

Mark Chicarelli,Karyn Bouhana, Richard K. Brizendine,LouAnn Cable, Michelle Crow,Brad Fell, J. E. Fischer,Jennifer Fulton, Anna L. Guarnieri,Ravi Jalluri, Hediyyih Knox, Keith A. Koch,

Cancer Researchno. 7_Supplement (2023): 1440-1440

Cited0Views0Bibtex

Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach

Minh H Nguyen,Hai-Fen Ye,Yao Xu,Lisa Truong,April Horsey, Peng Zhao,Evan D Styduhar,Michelle Frascella,Lynn Leffet,Kelly Federowicz,Elham Behshad,Anlai Wang,

ACS Med Chem Lett（2023）

Cited0Views0WOSBibtex

Pre-clinical In Vitro and In Vivo Characterization of a Novel EGFR Sparing ErbB2 Inhibitor with Activity Against Oncogenic ErbB2 Mutations

M.J. Chicarelli,K. Bouhana, L. Cable, M. Crow, B. Fell,J. Fischer, J. Fulton, A. Guarnieri,R. Jalluri, J. Robinson, F. Sullivan,S. Winski,

European Journal of Cancer（2022）

Cited0Views0Bibtex

Discovery of 1′-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3′-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach

Colin Zhang,Meizhong Xu,Chunhong He,Jincong Zhuo,David M Burns,Ding-Quan Qian,Qiyan Lin,Yun-Long Li,Lihua Chen,Eric Shi,Costas Agrios, Linkai Weng,

Bioorganic & Medicinal Chemistry Letters（2022）

Cited4Views0WOSBibtex

In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations

J. Fischer,K. Bouhana, M.J. Chicarelli, J. Dahlke, B. Fell, J. Fulton, A. Guarnieri, L. Haygood,R. Jalluri, A. Johnson, B. McLean, M. Max,

European Journal of Cancer（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn